Citations (184)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Li Wang, Qiao-Feng Zhao, Bing-Bing Yang, Hui-Jie Liang, Xian-E Zhang, Xiao-Yan Zhang, Wan-Jing Yang, Zhi-Yu Guo, Xin Xu, Fang Tian & Qing-Hua Wu. (2023) STAT3-EphA7 axis contributes to the progression of esophageal squamous cell carcinoma. Acta Oncologica 62:12, pages 1757-1766.
Read now
Read now
Ran Chen, Xiuying Lu, Zhen Li, Yajing Sun, Zhengxin He & Xiaoming Li. (2020) Dihydroartemisinin Prevents Progression and Metastasis of Head and Neck Squamous Cell Carcinoma by Inhibiting Polarization of Macrophages in Tumor Microenvironment. OncoTargets and Therapy 13, pages 3375-3387.
Read now
Read now
Xiaolei Zhang, Tao Lu, Yanhui Ma, Rui Li, Yingxin Pang, Hongluan Mao & Peishu Liu. (2020) Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo. OncoTargets and Therapy 13, pages 5069-5082.
Read now
Read now
Jingling Duan, Yang Yang, Zhen Wu, Shiang Lin, Chen Zhou, Guowen Sheng, Fan Yang, Lihui Bian, Xiaoling Zhang & Shengjun Xiao. (2019) F factor plasmid-mediated Epstein-Barr virus genome introduction establishes an EBV positive NPC cell model. Cancer Management and Research 11, pages 7377-7389.
Read now
Read now
Can Cui, Xiaojing Cheng, Liang Yan, Huirong Ding, Xiaoya Guan, Wenlong Zhang, Xiuyun Tian & Chunyi Hao. (2019) Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway. Cancer Management and Research 11, pages 6323-6341.
Read now
Read now
Iacopo Panarese, Gabriella Aquino, Andrea Ronchi, Francesco Longo, Marco Montella, Immacolata Cozzolino, Giuseppe Roccuzzo, Giuseppe Colella, Michele Caraglia & Renato Franco. (2019) Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route. Expert Review of Anticancer Therapy 19:2, pages 105-119.
Read now
Read now
Kyoko Inagaki-Ohara, Taisuke Kondo, Minako Ito & Akihiko Yoshimura. (2013) SOCS, inflammation, and cancer. JAK-STAT 2:3.
Read now
Read now
Malabika Sen & Jennifer R. Grandis. (2012) Nucleic acid-based approaches to STAT inhibition. JAK-STAT 1:4, pages 285-291.
Read now
Read now
Athanasios Kotsakis & Vassilis Georgoulias. (2010) Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer. Expert Opinion on Pharmacotherapy 11:14, pages 2363-2389.
Read now
Read now
ToddL. Watterson, Jared Sorensen, Randy Martin & RogerA. Coulombe$suffix/text()$suffix/text(). (2007) Effects of PM2.5 Collected from Cache Valley Utah on Genes Associated with the Inflammatory Response in Human Lung Cells. Journal of Toxicology and Environmental Health, Part A 70:20, pages 1731-1744.
Read now
Read now
Articles from other publishers (174)
Amal Kassab, Ishita Gupta & Ala-Eddin Al Moustafa. (2023) Role of E2F transcription factor in oral cancer: Recent insight and advancements. Seminars in Cancer Biology 92, pages 28-41.
Crossref
Crossref
Arshad Husain Rahmani, Ali Yousif Babiker & Shehwaz Anwar. (2023) Hesperidin, a Bioflavonoid in Cancer Therapy: A Review for a Mechanism of Action through the Modulation of Cell Signaling Pathways. Molecules 28:13, pages 5152.
Crossref
Crossref
Magdalena Bizoń, Zofia Awiżeń-Panufnik & Włodzimierz Sawicki. (2023) Comparison of Interleukin-6 with Other Markers in Diagnosis of Ovarian Cancer. Journal of Personalized Medicine 13:6, pages 980.
Crossref
Crossref
Manzar Alam, Gulam Mustafa Hasan, Sayed M. Eldin, Mohd Adnan, Muhammad Bilal Riaz, Asimul Islam, Ilyas Khan & Md. Imtaiyaz Hassan. (2023) Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma. Biomedicine & Pharmacotherapy 161, pages 114452.
Crossref
Crossref
Rawiah A. Alsiary, Talat Abdullah Albukhari & Waheed A. Filimban. 2023. Molecular Targets and Cancer Therapeutics (Part 1). Molecular Targets and Cancer Therapeutics (Part 1)
273
319
.
Qingfang Li, Yan Tie, Aqu Alu, Xuelei Ma & Huashan Shi. (2023) Targeted therapy for head and neck cancer: signaling pathways and clinical studies. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Zihan Yang, Yuan Gao, Weijie Wu, Honglei Mu, Ruiling Liu, Xiangjun Fang, Haiyan Gao & Hangjun Chen. (2023) The mitigative effect of lotus root (Nelumbo nucifera Gaertn) extract on acute alcoholism through activation of alcohol catabolic enzyme, reduction of oxidative stress, and protection of liver function. Frontiers in Nutrition 9.
Crossref
Crossref
Avinash Khadela, Yesha Shah, Priya Mistry, Kunjan Bodiwala & Avinash CB. (2023) Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects. Technology in Cancer Research & Treatment 22, pages 153303382211505.
Crossref
Crossref
Snežana Radisavljević, Ana Kesić, Dušan Ćoćić, Vladimir Marković, Jelena Milovanović, Biljana Petrović & Ana Rilak Simović. (2022) New gold(III) chlorophenyl terpyridine complex: Biomolecular interactions and anticancer activity against human oral squamous cell carcinoma. Applied Organometallic Chemistry 37:1.
Crossref
Crossref
Chengwu Xiao, Wei Zhang, Meimian Hua, Huan Chen, Bin Yang, Ye Wang & Qing Yang. (2022) RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop. Cellular & Molecular Biology Letters 27:1.
Crossref
Crossref
Elina Khatoon, Mangala Hegde, Aviral Kumar, Uzini Devi Daimary, Gautam Sethi, Anupam Bishayee & Ajaikumar B. Kunnumakkara. (2022) The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer. Archives of Pharmacal Research 45:8, pages 507-534.
Crossref
Crossref
Sutapa Mahata, Pranab K. Sahoo, Ranita Pal, Sinjini Sarkar, Tanuma Mistry, Sushmita Ghosh & Vilas D. Nasare. (2022) PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer. Medical Oncology 39:7.
Crossref
Crossref
Xiaoyuan Hu, Fenggang Xiang, Yuanyong Feng, Fei Gao, Shengyou Ge, Chengqin Wang, Xuan Zhang & Ning Wang. (2022) Neutrophils Promote Tumor Progression in Oral Squamous Cell Carcinoma by Regulating EMT and JAK2/STAT3 Signaling Through Chemerin. Frontiers in Oncology 12.
Crossref
Crossref
David A. Close & Paul A. Johnston. (2022) Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines. SLAS Discovery 27:1, pages 39-54.
Crossref
Crossref
Rajnikant Raut, Parth Gupta, Taruna Saini, Parul Mishra & Ashish Misra. 2022. Protein Kinase Inhibitors. Protein Kinase Inhibitors
479
503
.
Botros Y. Beshay, Amira A. Abdellatef, Yasser M. Loksha, Salwa M. Fahmy, Nargues S. Habib, Alaa El-Din A. Bekhit, Paris E. Georghiou, Yoshihiro Hayakawa & Adnan A. Bekhit. (2021) Design and synthesis of 2-Substituted-4-benzyl-5-methylimidazoles as new potential Anti-breast cancer agents to inhibit oncogenic STAT3 functions. Bioorganic Chemistry 113, pages 105033.
Crossref
Crossref
Ren Kong, Uddalak Bharadwaj, T. Kris Eckols, Mikhail Kolosov, Haoyi Wu, Francisco J. Santa Cruz-Pavlovich, Alison Shaw, Oluwatomilona I. Ifelayo, Hong Zhao, Moses M. Kasembeli, Stephen T.C. Wong & David J. Tweardy. (2021) Novel STAT3 small-molecule inhibitors identified by structure-based virtual ligand screening incorporating SH2 domain flexibility. Pharmacological Research 169, pages 105637.
Crossref
Crossref
Qian‐Ying Zhu, Ge‐Xin Zhao, Yan Li, Girish Talakatta, Hai‐Qiang Mai, Quynh‐Thu Le, Lawrence S. Young & Mu‐Sheng Zeng. (2021) Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma. MedComm 2:2, pages 175-206.
Crossref
Crossref
Nikita Aggarwal, Joni Yadav, Kulbhushan Thakur, Rakhi Bibban, Arun Chhokar, Tanya Tripathi, Anjali Bhat, Tejveer Singh, Mohit Jadli, Ujala Singh, Manoj K. Kashyap & Alok C. Bharti. (2020) Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Aliaa M. Mohassab, Heba A. Hassan, Dalia Abdelhamid & Mohamed Abdel-Aziz. (2020) STAT3 transcription factor as target for anti-cancer therapy. Pharmacological Reports 72:5, pages 1101-1124.
Crossref
Crossref
Dimitra P. Vageli, David Kasle, Sotirios G. Doukas, Panagiotis G. Doukas & Clarence T. Sasaki. (2020)
The temporal effects of topical NF-
κB
inhibition, in the
in vivo
prevention of bile-related oncogenic mRNA and miRNA phenotypes in murine hypopharyngeal mucosa: a preclinical model
. Oncotarget 11:35, pages 3303-3314.
Crossref
Crossref
Sotirios G. Doukas, Panagiotis G. Doukas, Clarence T. Sasaki & Dimitra Vageli. (2020) The in vivo preventive and therapeutic properties of curcumin in bile reflux‐related oncogenesis of the hypopharynx. Journal of Cellular and Molecular Medicine 24:18, pages 10311-10321.
Crossref
Crossref
Sabah Akhtar, Tayyiba A. Ali, Ammara Faiyaz, Omar S. Khan, Syed Shadab Raza, Michal Kulinski, Halima El Omri, Ajaz A. Bhat & Shahab Uddin. (2020) Cytokine-Mediated Dysregulation of Signaling Pathways in the Pathogenesis of Multiple Myeloma. International Journal of Molecular Sciences 21:14, pages 5002.
Crossref
Crossref
Tohid Gharibi, Zohreh Babaloo, Arezoo Hosseini, Meghdad Abdollahpour-alitappeh, Vida Hashemi, Faroogh Marofi, Kazem Nejati & Behzad Baradaran. (2020) Targeting STAT3 in cancer and autoimmune diseases. European Journal of Pharmacology 878, pages 173107.
Crossref
Crossref
Dohyun Kim, Minwoo Park, Iqra Haleem, Younghong Lee, Jain Koo, Young Chae Na, Gidong Song & Jaehwi Lee. (2020) Natural Product Ginsenoside 20(S)-25-Methoxyl-Dammarane-3β, 12β, 20-Triol in Cancer Treatment: A Review of the Pharmacological Mechanisms and Pharmacokinetics. Frontiers in Pharmacology 11.
Crossref
Crossref
Yannick Verhoeven, Sam Tilborghs, Julie Jacobs, Jorrit De Waele, Delphine Quatannens, Christophe Deben, Hans Prenen, Patrick Pauwels, Xuan Bich Trinh, An Wouters, Evelien L.J. Smits, Filip Lardon & Peter A. van Dam. (2020) The potential and controversy of targeting STAT family members in cancer. Seminars in Cancer Biology 60, pages 41-56.
Crossref
Crossref
Plabon Kumar Das, Mst. Ayesha Siddika, Saharia Yeasmin Asha, Suraiya Aktar, Md. Abdur Rakib, Jahan Ara Khanam, Suja Pillai & Farhadul Islam. (2019) MicroRNAs, a Promising Target for Breast Cancer Stem Cells. Molecular Diagnosis & Therapy 24:1, pages 69-83.
Crossref
Crossref
Sundas Arshad, Muhammad Naveed, Mahad Ullia, Khadija Javed, Ayesha Butt, Masooma Khawar & Fazeeha Amjad. (2020) Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges. Genetics and Molecular Biology 43:1.
Crossref
Crossref
Min Wu & Pinghu Zhang. (2020) EGFR-mediated autophagy in tumourigenesis and therapeutic resistance. Cancer Letters 469, pages 207-216.
Crossref
Crossref
Zhe Liu, Xianmin Ge, Yuchen Gu, Yingying Huang, Hao Liu, Meiling Yu & Yamin Liu. (2020) Small molecule STAT3 inhibitor, 6Br-6a suppresses breast cancer growth in vitro and in vivo. Biomedicine & Pharmacotherapy 121, pages 109502.
Crossref
Crossref
Severin, Frezzato, Visentin, Martini, Trimarco, Carraro, Tibaldi, Brunati, Piazza, Semenzato, Facco & Trentin. (2019) In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment. Cancers 11:12, pages 1939.
Crossref
Crossref
Ju-Hee Kang, Yeong-Su Jang, Ha Jung Lee, Chang-Yong Lee, Dong Yun Shin & Seung Hyun Oh. (2019) Inhibition of STAT3 signaling induces apoptosis and suppresses growth of lung cancer: good and bad. Laboratory Animal Research 35:1.
Crossref
Crossref
ShuJun Sun, JiaMei Wang, JingXu Wang, FuQuan Wang, ShangLong Yao & HaiFa Xia. (2019) Maresin 1 Mitigates Sepsis-Associated Acute Kidney Injury in Mice via Inhibition of the NF-κB/STAT3/MAPK Pathways. Frontiers in Pharmacology 10.
Crossref
Crossref
Nabil F. Saba, Zhuo Gerogia Chen, Missak Haigentz, Paolo Bossi, Alessandra Rinaldo, Juan P. Rodrigo, Antti A. Mäkitie, Robert P. Takes, Primoz Strojan, Jan B. Vermorken & Alfio Ferlito. (2019) Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): Forging a New Alliance. Molecular Cancer Therapeutics 18:11, pages 1909-1915.
Crossref
Crossref
Yi-Han Chiu, Yi-Yen Lee, Kuo-Chin Huang, Cheng-Chi Liu & Chen-Si Lin. (2019)
Dovitinib Triggers Apoptosis and Autophagic Cell Death by Targeting SHP-1/
p
-STAT3 Signaling in Human Breast Cancers
. Journal of Oncology 2019, pages 1-14.
Crossref
Crossref
Andrea Li Ann Wong, Gregory Lucien Bellot, Jayshree L. Hirpara & Shazib Pervaiz. (2019) Understanding the cancer stem cell phenotype: A step forward in the therapeutic management of cancer. Biochemical Pharmacology 162, pages 79-88.
Crossref
Crossref
Santina Venuto, Stefano Castellana, Maria Monti, Irene Appolloni, Caterina Fusilli, Carmela Fusco, Piero Pucci, Paolo Malatesta, Tommaso Mazza, Giuseppe Merla & Lucia Micale. (2019) TRIM8-driven transcriptomic profile of neural stem cells identified glioma-related nodal genes and pathways. Biochimica et Biophysica Acta (BBA) - General Subjects 1863:2, pages 491-501.
Crossref
Crossref
Yang Yang & Zhi Shi. 2019. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy
53
65
.
Jenny D. Beebe, Jing-Yuan Liu & Jian-Ting Zhang. (2018) Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?. Pharmacology & Therapeutics 191, pages 74-91.
Crossref
Crossref
Loukik Arora, Alan Kumar, Frank Arfuso, Wee Chng & Gautam Sethi. (2018) The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies. Cancers 10:9, pages 327.
Crossref
Crossref
Hongmin Lu, Shibo Wu, Huafei Chen, Ying Huang, Guoqin Qiu, Lingxiang Liu & Yong Li. (2018) Crizotinib induces apoptosis of lung cancer cells through JAK-STAT pathway. Oncology Letters.
Crossref
Crossref
Alice West, Vanessa Tsui, Stanley Stylli, Hong Nguyen, Andrew Morokoff, Andrew Kaye & Rodney Luwor. (2018) The role of interleukin‑6‑STAT3 signalling in glioblastoma (Review). Oncology Letters.
Crossref
Crossref
Milad Rouhimoghadam, Shahrokh Safarian, Jason S. Carroll, Nader Sheibani & Gholamreza Bidkhori. (2018) Tamoxifen-Induced Apoptosis of MCF-7 Cells via GPR30/PI3K/MAPKs Interactions: Verification by ODE Modeling and RNA Sequencing. Frontiers in Physiology 9.
Crossref
Crossref
Elizabeth Cedars, Daniel E. Johnson & Jennifer R. Grandis. 2018. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer
155
184
.
Barbara Burtness & Erica A. Golemis. 2018. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer
1
5
.
Paul A. Johnston, Malabika Sen, Yun Hua, Daniel P. Camarco, Tong Ying Shun, John S. Lazo & Jennifer R. Grandis. 2018. High Content Screening. High Content Screening
229
244
.
Wendy D'SouzaDhananjaya Saranath. (2017) OMICS, Oral Cancer Molecular Landscapes, and Clinical Practice. OMICS: A Journal of Integrative Biology 21:12, pages 689-703.
Crossref
Crossref
Xiao-Long Fu, Wei Duan, Chong-Yu Su, Fang-Yuan Mao, Yi-Ping Lv, Yong-Sheng Teng, Pei-Wu Yu, Yuan Zhuang & Yong-Liang Zhao. (2017) Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression. Cancer Immunology, Immunotherapy 66:12, pages 1597-1608.
Crossref
Crossref
Aarti Bhatia & Barbara Burtness. (2017) Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck. Cancers 9:9, pages 113.
Crossref
Crossref
Tiejun Zhang & Di Zhang. (2017) Integrating omics data and protein interaction networks to prioritize driver genes in cancer. Oncotarget 8:35, pages 58050-58060.
Crossref
Crossref
Malabika Sen, Paul A. Johnston, Netanya I. Pollock, Kara DeGrave, Sonali C. Joyce, Maria L. Freilino, Yun Hua, Daniel P. Camarco, David A. Close, Donna M. Huryn, Peter Wipf & Jennifer R. Grandis. (2017) Mechanism of action of selective inhibitors of IL-6 induced STAT3 pathway in head and neck cancer cell lines. Journal of Chemical Biology 10:3, pages 129-141.
Crossref
Crossref
Jing Gao, Junling Chen, Mingjun Cai, Haijiao Xu, Junguang Jiang, Ti Tong & Hongda Wang. (2017) Clustered localization of STAT3 during the cell cycle detected by super-resolution fluorescence microscopy. Methods and Applications in Fluorescence 5:2, pages 024004.
Crossref
Crossref
Lee-Han Kim, Ji-Ae Shin, Boonsil Jang, In-Hyoung Yang, Dong-Hoon Won, Joseph H. Jeong, Tae-Ho Chung, Nam-Pyo Cho & Sung-Dae Cho. (2017) Sorafenib potentiates ABT-737-induced apoptosis in human oral cancer cells. Archives of Oral Biology 73, pages 1-6.
Crossref
Crossref
Dongkyoo Park, Neha Merchant & Inho Choi. 2017. Role of Transcription Factors in Gastrointestinal Malignancies. Role of Transcription Factors in Gastrointestinal Malignancies
479
493
.
R.L. Ferris, J.L. Geiger, S. Trivedi, N.C. Schmitt, D.E. Heron, J.T. Johnson, S. Kim, U. Duvvuri, D.A. Clump, J.E. Bauman, J.P. Ohr, W.E. Gooding & A. Argiris. (2016) Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer. Annals of Oncology 27:12, pages 2257-2262.
Crossref
Crossref
Toru Oi, Kunihiro Asanuma, Akihiko Matsumine, Takao Matsubara, Tomoki Nakamura, Takahiro Iino, Yumiko Asanuma, Mikinobu Goto, Kazuma Okuno, Takuya Kakimoto, Yuki Yada & Akihiro Sudo. (2016) STAT3 inhibitor, cucurbitacin�I, is a novel therapeutic agent for osteosarcoma. International Journal of Oncology.
Crossref
Crossref
Z Zhou, M Wang, J Li, M Xiao, Y E Chin, J Cheng, E T H Yeh, J Yang & J Yi. (2016) SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer. Oncogene 35:45, pages 5826-5838.
Crossref
Crossref
Ying Gu, Guan Gao, Ning Ma, Lin Ye, Li Zhang, Xu Gao & Zhuo Zhang. (2016) CNTF protects neurons from hypoxic injury through the activation of STAT3pTyr705. International Journal of Molecular Medicine.
Crossref
Crossref
Chadrashekar Kagepura Thammaiah & Shankar Jayaram. (2016) Role of let-7 family microRNA in breast cancer. Non-coding RNA Research 1:1, pages 77-82.
Crossref
Crossref
Bo-Ra Lee, Bo-Eun Kwon, Eun-Hye Hong, Aeri Shim, Jae-Hyoung Song, Hong-Min Kim, Sun-Young Chang, Yeon-Jeong Kim, Mi-Na Kweon, Je-In Youn & Hyun-Jeong Ko. (2016) Interleukin-10 attenuates tumour growth by inhibiting interleukin-6/signal transducer and activator of transcription 3 signalling in myeloid-derived suppressor cells. Cancer Letters 381:1, pages 156-164.
Crossref
Crossref
Noah D. Peyser, Lin Wang, Yan Zeng, Marie Acquafondata, Maria Freilino, Hua Li, Malabika Sen, William E. Gooding, Masanobu Satake, Zhenghe Wang, Daniel E. Johnson & Jennifer R. Grandis. (2016) STAT3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell Carcinoma. Cancer Prevention Research 9:8, pages 657-663.
Crossref
Crossref
Matthew G. LaPorte, Zhuzhu Wang, Raffaele Colombo, Atefeh Garzan, Vsevolod A. Peshkov, Mary Liang, Paul A. Johnston, Mark E. Schurdak, Malabika Sen, Daniel P. Camarco, Yun Hua, Netanya I. Pollock, John S. Lazo, Jennifer R. Grandis, Peter Wipf & Donna M. Huryn. (2016) Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors. Bioorganic & Medicinal Chemistry Letters 26:15, pages 3581-3585.
Crossref
Crossref
IOANNIS GKOUVERIS, NIKOLAOS NIKITAKIS, MARIA KARANIKOU, GEORGE RASSIDAKIS & ALEXANDRA SKLAVOUNOU. (2016) JNK1/2 expression and modulation of STAT3 signaling in oral cancer. Oncology Letters 12:1, pages 699-706.
Crossref
Crossref
Edna Zhi Pei Chai, Muthu K. Shanmugam, Frank Arfuso, Arunasalam Dharmarajan, Chao Wang, Alan Prem Kumar, Ramar Perumal Samy, Lina H.K. Lim, Lingzhi Wang, Boon Cher Goh, Kwang Seok Ahn, Kam Man Hui & Gautam Sethi. (2016) Targeting transcription factor STAT3 for cancer prevention and therapy. Pharmacology & Therapeutics 162, pages 86-97.
Crossref
Crossref
Jessica L. Geiger, Jennifer R. Grandis & Julie E. Bauman. (2016) The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations. Oral Oncology 56, pages 84-92.
Crossref
Crossref
Lifeng Jia, Qi Song, Chenyang Zhou, Xiaoming Li, Lihong Pi, Xiuru Ma, Hui Li, Xiuying Lu & Yupeng Shen. (2016) Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling. PLOS ONE 11:1, pages e0147157.
Crossref
Crossref
Megan E. Brown, Misty D. Bear, Thomas J. Rosol, Chris Premanandan, William C. Kisseberth & Cheryl A. London. (2015) Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma. BMC Veterinary Research 11:1.
Crossref
Crossref
Lama Tarayrah, Yuping Li, Qiang Gan & Xin Chen. (2015) Epigenetic regulator Lid maintains germline stem cells through regulating JAK-STAT signaling pathway activity. Biology Open 4:11, pages 1518-1527.
Crossref
Crossref
Manjulata SinghDavid A. CloseShilpaa MukundanPaul A. JohnstonShilpa Sant. (2015) Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway Activation. ASSAY and Drug Development Technologies 13:9, pages 570-583.
Crossref
Crossref
Jia Kang, Stephen Jun Fei Chong, Vignette Zi Qi Ooi, Shireen Vali, Ansu Kumar, Shweta Kapoor, Taher Abbasi, Jayshree L. Hirpara, Thomas Loh, Boon Cher Goh & Shazib Pervaiz. (2015)
Overexpression of Bcl-2 induces STAT-3 activation
via
an increase in mitochondrial superoxide
. Oncotarget 6:33, pages 34191-34205.
Crossref
Crossref
Nicole C. Schmitt, Sumita Trivedi & Robert L. Ferris. (2015) STAT1 Activation Is Enhanced by Cisplatin and Variably Affected by EGFR Inhibition in HNSCC Cells. Molecular Cancer Therapeutics 14:9, pages 2103-2111.
Crossref
Crossref
Paul A. JohnstonMalabika SenYun HuaDaniel P. CamarcoTong Ying ShunJohn S. LazoGabriela Mustata WilsonLynn O. ResnickMatthew G. LaPortePeter WipfDonna M. HurynJennifer R. Grandis. (2015) HCS Campaign to Identify Selective Inhibitors of IL-6-Induced STAT3 Pathway Activation in Head and Neck Cancer Cell Lines. ASSAY and Drug Development Technologies 13:7, pages 356-376.
Crossref
Crossref
Noa Noy, Li Li, Matthew V. Abola & Nathan A. Berger. (2015) Is retinol binding protein 4 a link between adiposity and cancer?. Hormone Molecular Biology and Clinical Investigation 23:2, pages 39-46.
Crossref
Crossref
Shrikant Balasaheb Mali. (2015) Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer. Oral Oncology 51:6, pages 565-569.
Crossref
Crossref
David J. Wisniewski, Tao Ma & Abraham Schneider. (2015) Advances in the Chemopreventive Targeting of Oral Carcinogenesis. Current Oral Health Reports 2:2, pages 63-72.
Crossref
Crossref
Xiaokui Yu, Li He, Peng Cao & Qiang Yu. (2015) Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3. PLOS ONE 10:5, pages e0128406.
Crossref
Crossref
Fang Liu, Zhuming Bi, Eric L. Xu, Qin Ga, Quanyu Yang, Yingzhong Yang, Lan Ma, Tana Wuren & Rili Ge. (2012) An integrated systems approach to plateau ecosystem management—a scientific application in Qinghai and Tibet plateau. Information Systems Frontiers 17:2, pages 337-350.
Crossref
Crossref
Malabika Sen, Netanya I. Pollock, John Black, Kara A. DeGrave, Sarah Wheeler, Maria L. Freilino, Sonali Joyce, Vivian W.Y. Lui, Yan Zeng, Simion I. Chiosea & Jennifer R. Grandis. (2015) JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth. Neoplasia 17:3, pages 256-264.
Crossref
Crossref
Xinguang Han, Yongfu Han, Huifeng Jiao & Yaqiong Jie. (2015) 14-3-3ζ Regulates Immune Response through Stat3 Signaling in Oral Squamous Cell Carcinoma. Molecules and Cells 38:2, pages 112-121.
Crossref
Crossref
Kenichi Kobayashi, Yukiko Kobayashi, Misato Nakamura, Osamu Tamura & Hiroshi Kogen. (2015)
Establishment of Relative and Absolute Configurations of Phaeosphaeride A: Total Synthesis of
ent
-Phaeosphaeride A
. The Journal of Organic Chemistry 80:2, pages 1243-1248.
Crossref
Crossref
. (2015) 14-3-3ζ Regulates Immune Response through Stat3 Signaling in Oral Squamous Cell Carcinoma. Molecules and Cells.
Crossref
Crossref
S. Trivedi, F. Concha-Benavente, R.M. Srivastava, H.B. Jie, S.P. Gibson, N.C. Schmitt & R.L. Ferris. (2015) Immune biomarkers of anti-EGFR monoclonal antibody therapy. Annals of Oncology 26:1, pages 40-47.
Crossref
Crossref
Ka-Ho Leung, Li-Juan Liu, Sheng Lin, Lihua Lu, Hai-Jing Zhong, Dewi Susanti, Weidong Rao, Modi Wang, Weng Ian Che, Daniel Shiu-Hin Chan, Chung-Hang Leung, Philip Wai Hong Chan & Dik-Lung Ma. (2015) Discovery of a small-molecule inhibitor of STAT3 by ligand-based pharmacophore screening. Methods 71, pages 38-43.
Crossref
Crossref
Subhasis Barik, Saptak Banerjee, Madhurima Sarkar, Avishek Bhuniya, Soumyabrata Roy, Anamika Bose & Rathindranath Baral. (2015) Neem leaf glycoprotein optimizes effector and regulatory functions within tumor microenvironment to intervene therapeutically the growth of B16 melanoma in C57BL/6 mice. Trials in Vaccinology 4, pages e80-e87.
Crossref
Crossref
Praveena S. Thiagarajan & Ofer Reizes. 2015. Murine Models, Energy Balance, and Cancer. Murine Models, Energy Balance, and Cancer
127
151
.
IOANNIS GKOUVERIS, NIKOLAOS NIKITAKIS, MARIA KARANIKOU, GEORGE RASSIDAKIS & ALEXANDRA SKLAVOUNOU. (2014) Erk1/2 activation and modulation of STAT3 signaling in oral cancer. Oncology Reports 32:5, pages 2175-2182.
Crossref
Crossref
Daniel C. Berry, Liraz Levi & Noa Noy. (2014) Holo-Retinol–Binding Protein and Its Receptor STRA6 Drive Oncogenic Transformation. Cancer Research 74:21, pages 6341-6351.
Crossref
Crossref
C Saiz-Ladera, M F Lara, M Garín, S Ruiz, M Santos, C Lorz, R García-Escudero, M Martínez-Fernández, A Bravo, O Fernández-Capetillo, C Segrelles & J M Paramio. (2013) p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia. Oncogene 33:37, pages 4599-4612.
Crossref
Crossref
Shengjuan Shao, Rilei Yu, Yanqing Yu & Yanni Li. (2014) Dual-inhibitors of STAT5 and STAT3: studies from molecular docking and molecular dynamics simulations. Journal of Molecular Modeling 20:8.
Crossref
Crossref
Hai-Feng Zhang & Raymond Lai. (2014) STAT3 in Cancer—Friend or Foe?. Cancers 6:3, pages 1408-1440.
Crossref
Crossref
L-J Liu, K-H Leung, D S-H Chan, Y-T Wang, D-L Ma & C-H Leung. (2014) Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening. Cell Death & Disease 5:6, pages e1293-e1293.
Crossref
Crossref
SHU-WEI WANG & YUE-MING SUN. (2014) The IL-6/JAK/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer. International Journal of Oncology 44:4, pages 1032-1040.
Crossref
Crossref
Kodappully Sivaraman Siveen, Sakshi Sikka, Rohit Surana, Xiaoyun Dai, Jingwen Zhang, Alan Prem Kumar, Benny K.H. Tan, Gautam Sethi & Anupam Bishayee. (2014) Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1845:2, pages 136-154.
Crossref
Crossref
Jonah D. Klein, Daisuke Sano, Malabika Sen, Jeffrey N. Myers, Jennifer R. Grandis & Seungwon Kim. (2014) STAT3 Oligonucleotide Inhibits Tumor Angiogenesis in Preclinical Models of Squamous Cell Carcinoma. PLoS ONE 9:1, pages e81819.
Crossref
Crossref
Malabika Sen, Kathleen Paul, Maria L. Freilino, Hua Li, Changyou Li, Daniel E. Johnson, Lin Wang, Julie Eiseman & Jennifer R. Grandis. (2013) Systemic Administration of a Cyclic Signal Transducer and Activator of Transcription 3 (STAT3) Decoy Oligonucleotide Inhibits Tumor Growth without Inducing Toxicological Effects. Molecular Medicine 20:1, pages 46-56.
Crossref
Crossref
Paul A. JohnstonMalabika SenYun HuaDaniel CamarcoTong Ying ShunJohn S. LazoJennifer R. Grandis. (2014) High-Content pSTAT3/1 Imaging Assays to Screen for Selective Inhibitors of STAT3 Pathway Activation in Head and Neck Cancer Cell Lines. ASSAY and Drug Development Technologies 12:1, pages 55-79.
Crossref
Crossref
Bhavana S. Vangara & Jennifer R. Grandis. 2014. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer
163
177
.
Barbara Burtness & Erica A. Golemis. 2014. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer
1
5
.
Carter Van Waes, Yansong Bian, Clint T. Allen, John C. Morris & Zhong Chen. 2015. Molecular Oncology. Molecular Oncology
686
692
.
Qing CaoYun-Yun LiWen-Feng HeZhong-Zu ZhangQin Zhou, Xin LiuYang ShenTing-Ting Huang. (2013) Interplay between microRNAs and the STAT3 signaling pathway in human cancers. Physiological Genomics 45:24, pages 1206-1214.
Crossref
Crossref
Feng Li, Muthu K. Shanmugam, Luxi Chen, Snehajyoti Chatterjee, Jeelan Basha, Alan Prem Kumar, Tapas K. Kundu & Gautam Sethi. (2013) Garcinol, a Polyisoprenylated Benzophenone Modulates Multiple Proinflammatory Signaling Cascades Leading to the Suppression of Growth and Survival of Head and Neck Carcinoma. Cancer Prevention Research 6:8, pages 843-854.
Crossref
Crossref
Mozaffarul Islam, Smita Sharma, Bhavna Kumar & Theodoros N. Teknos. (2013) Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis. Oral Oncology 49:8, pages 778-786.
Crossref
Crossref
Govinda Raju Yedida, Siddavaram Nagini & Rajakishore Mishra. (2013) The importance of oncogenic transcription factors for oral cancer pathogenesis and treatment. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 116:2, pages 179-188.
Crossref
Crossref
Xiaolei Zhang. (2013) Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in�vivo. International Journal of Molecular Medicine.
Crossref
Crossref
Xiaodong Sun, Jie Li, Gabriel Sica, Song‐Qing Fan, Yuxiang Wang, Zhengjia Chen, Susan Muller, Zhuo (Georgia) Chen, Xiaoying Fu, Xue‐Yuan Dong, Peng Guo, Dong M. Shin & Jin‐Tang Dong. (2012) Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma. Head & Neck 35:7, pages 1007-1014.
Crossref
Crossref
Yeung Ho, Sai-Wah Tsao, Musheng Zeng & Vivian Wai Yan Lui. (2013) STAT3 as a therapeutic target for Epstein-Barr virus (EBV) – associated nasopharyngeal carcinoma. Cancer Letters 330:2, pages 141-149.
Crossref
Crossref
Jong Hun Lee, Tin Oo Khor, Limin Shu, Zheng-Yuan Su, Francisco Fuentes & Ah-Ng Tony Kong. (2013) Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression. Pharmacology & Therapeutics 137:2, pages 153-171.
Crossref
Crossref
Yubo Fan, Ren Kong, David J. Tweardy & Stephen T. Wong. (2013) WITHDRAWN: Intrinsic molecular characteristics of inhibiting STAT3 activation and dimerization through targeting the phosphotyrosine binding site within the SH2 domain—A molecular dynamics study. Journal of Structural Biology.
Crossref
Crossref
Jason I Couto, Misty D Bear, Jiayuh Lin, Michael Pennel, Samuel K Kulp, William C Kisseberth & Cheryl A London. (2012) Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines. BMC Veterinary Research 8:1.
Crossref
Crossref
Makoto Adachi, Caixia Cui, Cristina T. Dodge, Mihir K. Bhayani & Stephen Y. Lai. (2012) Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma. Oral Oncology 48:12, pages 1220-1226.
Crossref
Crossref
Gholamreza Bidkhori, Ali Moeini & Ali Masoudi-Nejad. (2012) Modeling of Tumor Progression in NSCLC and Intrinsic Resistance to TKI in Loss of PTEN Expression. PLoS ONE 7:10, pages e48004.
Crossref
Crossref
XIAOCHUN WANG, PHILIP J. CROWE, DAVID GOLDSTEIN & JIA-LIN YANG. (2012) STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers. International Journal of Oncology 41:4, pages 1181-1191.
Crossref
Crossref
Jonah D. Klein, Apostolos Christopoulos, Sun M. Ahn, William E. Gooding, Jennifer R. Grandis & Seungwon Kim. (2012) Antitumor effect of vandetanib through EGFR inhibition in head and neck squamous cell carcinoma. Head & Neck 34:9, pages 1269-1276.
Crossref
Crossref
Priya Koppikar & Jacqueline Bromberg. (2012) STATe-of-the-Art Approach: Using Oligonucleotide Decoys to Target the “Undruggable”. Cancer Discovery 2:8, pages 670-672.
Crossref
Crossref
Malabika Sen, Sufi M. Thomas, Seungwon Kim, Joanne I. Yeh, Robert L. Ferris, Jonas T. Johnson, Umamaheswar Duvvuri, Jessica Lee, Nivedita Sahu, Sonali Joyce, Maria L. Freilino, Haibin Shi, Changyou Li, Danith Ly, Srinivas Rapireddy, Jonathan P. Etter, Pui-Kai Li, Lin Wang, Simion Chiosea, Raja R. Seethala, William E. Gooding, Xiaomin Chen, Naftali Kaminski, Kusum Pandit, Daniel E. Johnson & Jennifer R. Grandis. (2012) First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy. Cancer Discovery 2:8, pages 694-705.
Crossref
Crossref
Christopher Jackson, Jacob Ruzevick, Anubhav G. Amin & Michael Lim. (2012) Potential Role for STAT3 Inhibitors in Glioblastoma. Neurosurgery Clinics of North America 23:3, pages 379-389.
Crossref
Crossref
S. K. Kundu & M. Nestor. (2012) Targeted therapy in head and neck cancer. Tumor Biology 33:3, pages 707-721.
Crossref
Crossref
XIRUI WANG, LEI CAO, YINGYI WANG, XIEFENG WANG, NING LIU & YONGPING YOU. (2012) Regulation of let-7 and its target oncogenes (Review). Oncology Letters 3:5, pages 955-960.
Crossref
Crossref
Victoria Cohen-Kaplan, Jenny Jrbashyan, Yoav Yanir, Inna Naroditsky, Ofer Ben-Izhak, Neta Ilan, Ilana Doweck & Israel Vlodavsky. (2012) Heparanase Induces Signal Transducer and Activator of Transcription (STAT) Protein Phosphorylation. Journal of Biological Chemistry 287:9, pages 6668-6678.
Crossref
Crossref
Roland H. Stauber, Shirley K. Knauer, Negusse Habtemichael, Carolin Bier, Britta Unruhe, Simona Weisheit, Stephanie Spange, Frank Nonnenmacher, Verena Fetz, Torsten Ginter, Sigrid Reichardt, Claus Liebmann, Günter Schneider & Oliver H. Krämer. (2011) A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer. Oncotarget 3:1, pages 31-43.
Crossref
Crossref
Marco A. De Velasco & Hirotsugu Uemura. (2012) Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway. Advances in Urology 2012, pages 1-12.
Crossref
Crossref
Daniel C. Berry & Noa Noy. (2012) Signaling by vitamin A and retinol-binding protein in regulation of insulin responses and lipid homeostasis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1821:1, pages 168-176.
Crossref
Crossref
David K. Lam & Brian L. Schmidt. 2012. Current Therapy In Oral and Maxillofacial Surgery. Current Therapy In Oral and Maxillofacial Surgery
92
101
.
Meng Sun, Chengfei Liu, Nagalakshmi Nadiminty, Wei Lou, Yezi Zhu, Joy Yang, Christopher P. Evans, Qinghua Zhou & Allen C. Gao. (2011) Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. The Prostate 72:1, pages 82-89.
Crossref
Crossref
Natalia A. Kokorina, James S. LewisJr.Jr., Stanislav O. Zakharkin, Paul H. Krebsbach & Brian Nussenbaum. (2012) rhBMP-2 has adverse effects on human oral carcinoma cell lines in vivo. The Laryngoscope 122:1, pages 95-102.
Crossref
Crossref
Ranee Mehra, Ilya G. Serebriiskii, Roland L. DunbrackJr.Jr., Matthew K. Robinson, Barbara Burtness & Erica A. Golemis. (2011) Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer. Drug Resistance Updates 14:6, pages 260-279.
Crossref
Crossref
Jihoon Kim, Yu-Jin Lee, Dae-Seop Shin, Sun-Hee Jeon, Kwang-Hee Son, Dong Cho Han, Seung-Nam Jung, Tae-Kwang Oh & Byoung-Mog Kwon. (2011) Cosmomycin C inhibits signal transducer and activator of transcription 3 (STAT3) pathways in MDA-MB-468 breast cancer cell. Bioorganic & Medicinal Chemistry 19:24, pages 7582-7589.
Crossref
Crossref
Lisa A. Elferink & Vicente A. Resto. (2011) Receptor-Tyrosine-Kinase-Targeted Therapies for Head and Neck Cancer. Journal of Signal Transduction 2011, pages 1-11.
Crossref
Crossref
Daniel C. Berry, Hui Jin, Avijit Majumdar & Noa Noy. (2011) Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses. Proceedings of the National Academy of Sciences 108:11, pages 4340-4345.
Crossref
Crossref
Jorge M. Blando, Steve Carbajal, Erika Abel, Linda Beltran, Claudio Conti, Susan Fischer & John DiGiovanni. (2011) Cooperation between Stat3 and Akt Signaling Leads to Prostate Tumor Development in Transgenic Mice. Neoplasia 13:3, pages 254-IN12.
Crossref
Crossref
Rebecca J. Leeman-Neill, Raja R. Seethala, Shivendra V. Singh, Maria L. Freilino, Joseph S. Bednash, Sufi M. Thomas, Mary C. Panahandeh, William E. Gooding, Sonali C. Joyce, Mark W. Lingen, Daniel B. Neill & Jennifer R. Grandis. (2011) Inhibition of EGFR-STAT3 Signaling with Erlotinib Prevents Carcinogenesis in a Chemically-Induced Mouse Model of Oral Squamous Cell Carcinoma. Cancer Prevention Research 4:2, pages 230-237.
Crossref
Crossref
Mitchell J. Frederick, Amy J. VanMeter, Mayur A. Gadhikar, Ying C. Henderson, Hui Yao, Curtis C. Pickering, Michelle D. Williams, Adel K. El-Naggar, Vlad Sandulache, Emily Tarco, Jeffrey N. Myers, Gary L. Clayman, Lance A. Liotta, Emanuel F. PetricoinIIIIII, Valerie S. Calvert, Valentina Fodale, Jing Wang & Randal S. Weber. (2011) Phosphoproteomic Analysis of Signaling Pathways in Head and Neck Squamous Cell Carcinoma Patient Samples. The American Journal of Pathology 178:2, pages 548-571.
Crossref
Crossref
Vikas Kumar Srivastava, Rishi Kumar Gara, M.L.B. Bhatt, D.P. Sahu & Durga Prasad Mishra. (2011) Centchroman inhibits proliferation of head and neck cancer cells through the modulation of PI3K/mTOR Pathway. Biochemical and Biophysical Research Communications 404:1, pages 40-45.
Crossref
Crossref
Carolin M. Grimminger & Peter V. Danenberg. (2010) Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review. European Archives of Oto-Rhino-Laryngology 268:1, pages 5-16.
Crossref
Crossref
Barry L. Ziober, Joseph O. Humtsoe & Randall H. Kramer. 2011. Signaling Pathways in Squamous Cancer. Signaling Pathways in Squamous Cancer
1
19
.
Zhenlian Wang, Feijun Luo, Lili Li, Lifang Yang, Duosha Hu, Xiaoqian Ma, Zhongxin Lu, Lunquan Sun & Ya Cao. (2010) STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. European Journal of Cancer 46:16, pages 2996-3006.
Crossref
Crossref
Junaid A. Khan, Maohua Cao, Bum-Yong Kang, Yong Liu, Jawahar L. Mehta & Paul L. Hermonat. (2010) AAV/hSTAT3-gene delivery lowers aortic inflammatory cell infiltration in LDLR KO mice on high cholesterol. Atherosclerosis 213:1, pages 59-66.
Crossref
Crossref
S E Wheeler, S Suzuki, S M Thomas, M Sen, R J Leeman-Neill, S I Chiosea, C-T Kuan, D D Bigner, W E Gooding, S Y Lai & J R Grandis. (2010) Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation. Oncogene 29:37, pages 5135-5145.
Crossref
Crossref
Tingyan Liu, Huaguang Peng, Meixia Zhang, Yihui Deng & Zhenghu Wu. (2010) Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin. European Journal of Pharmacology 641:1, pages 15-22.
Crossref
Crossref
Rebecca J. Leeman-Neill, Quan Cai, Sonali C. Joyce, Sufi M. Thomas, Neil E. Bhola, Daniel B. Neill, Jack L. Arbiser & Jennifer R. Grandis. (2010) Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors. Clinical Cancer Research 16:9, pages 2571-2579.
Crossref
Crossref
R. Behera, V. Kumar, K. Lohite, S. Karnik & G. C. Kundu. (2009) Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis 31:2, pages 192-200.
Crossref
Crossref
Li Zhang, Weixiang Guo, Qi Chen, Xiujun Fan, Ying Zhang & Enkui Duan. (2009) Adam12 plays a role during uterine decidualization in mice. Cell and Tissue Research 338:3, pages 413-421.
Crossref
Crossref
Rebecca J. Leeman-Neill, Sarah E. Wheeler, Shivendra V. Singh, Sufi M. Thomas, Raja R. Seethala, Daniel B. Neill, Mary C. Panahandeh, Eun-Ryeong Hahm, Sonali C. Joyce, Malabika Sen, Quan Cai, Maria L. Freilino, Changyou Li, Daniel E. Johnson & Jennifer R. Grandis. (2009) Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3. Carcinogenesis 30:11, pages 1848-1856.
Crossref
Crossref
Melanie IssigonisNatalia TulinaMargaret de CuevasCrista BrawleyLaurel SandlerErika Matunis. (2009)
JAK-STAT Signal Inhibition Regulates Competition in the
Drosophila
Testis Stem Cell Niche
. Science 326:5949, pages 153-156.
Crossref
Crossref
Frederick Wang, Pattatheyil Arun, Jay Friedman, Zhong Chen & Carter Van Waes. (2009) Current and potential inflammation targeted therapies in head and neck cancer. Current Opinion in Pharmacology 9:4, pages 389-395.
Crossref
Crossref
Vladimir Ratushny, Igor Astsaturov, Barbara A. Burtness, Erica A. Golemis & Joshua S. Silverman. (2009) Targeting EGFR resistance networks in head and neck cancer. Cellular Signalling 21:8, pages 1255-1268.
Crossref
Crossref
Kathleen G. Neiva, Zhaocheng Zhang, Marta Miyazawa, Kristy A. Warner, Elisabeta Karl & Jacques E. Nör. (2009) Cross talk Initiated by Endothelial Cells Enhances Migration and Inhibits Anoikis of Squamous Cell Carcinoma Cells through STAT3/Akt/ERK Signaling. Neoplasia 11:6, pages 583-IN14.
Crossref
Crossref
Rakesh K. Singh, Ying Dai, Jeff L. Staudinger & Nancy A. Muma. (2008) Activation of the JAK-STAT pathway is necessary for desensitization of 5-HT2A receptor-stimulated phospholipase C signalling by olanzapine, clozapine and MDL 100907. The International Journal of Neuropsychopharmacology 12:05, pages 651.
Crossref
Crossref
Malabika Sen, Patricia J. Tosca, Christa Zwayer, Michael J. Ryan, Jerry D. Johnson, Katherine A. B. Knostman, Patricia C. Giclas, James O. Peggins, Joseph E. Tomaszewski, Timothy P. McMurray, Changyou Li, Michael S. Leibowitz, Robert L. Ferris, William E. Gooding, Sufi M. Thomas, Daniel E. Johnson & Jennifer R. Grandis. (2008) Lack of toxicity of a STAT3 decoy oligonucleotide. Cancer Chemotherapy and Pharmacology 63:6, pages 983-995.
Crossref
Crossref
Alfredo A. Molinolo, Panomwat Amornphimoltham, Cristiane H. Squarize, Rogerio M. Castilho, Vyomesh Patel & J. Silvio Gutkind. (2009) Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncology 45:4-5, pages 324-334.
Crossref
Crossref
Marta Moral, Carmen Segrelles, M. Fernanda Lara, Ana Belén Martínez-Cruz, Corina Lorz, Mirentxu Santos, Ramón García-Escudero, Jerry Lu, Kaoru Kiguchi, Agueda Buitrago, Clotilde Costa, Cristina Saiz, Jose L. Rodriguez-Peralto, Francisco J. Martinez-Tello, Maria Rodriguez-Pinilla, Montserrat Sanchez-Cespedes, Marina Garín, Teresa Grande, Ana Bravo, John DiGiovanni & Jesús M. Paramio. (2009)
Akt Activation Synergizes with
Trp53
Loss in Oral Epithelium to Produce a Novel Mouse Model for Head and Neck Squamous Cell Carcinoma
. Cancer Research 69:3, pages 1099-1108.
Crossref
Crossref
Sarah Morgan & Jennifer R. Grandis. (2009) ErbB receptors in the biology and pathology of the aerodigestive tract. Experimental Cell Research 315:4, pages 572-582.
Crossref
Crossref
John C. Sitko, Brian Yeh, Moonhong Kim, Hong Zhou, Giichi Takaesu, Akihiko Yoshimura, William H. McBride, Anahid Jewett, Christina A.M. Jamieson & Nicholas A. Cacalano. (2008) SOCS3 regulates p21 expression and cell cycle arrest in response to DNA damage. Cellular Signalling 20:12, pages 2221-2230.
Crossref
Crossref
Alexander Gelbard, Michael E. Kupferman, Samar A. Jasser, Wantao Chen, Adel K. El-Naggar, Jeffrey N. Myers & Ehab Y. Hanna. (2008) An Orthotopic Murine Model of Sinonasal Malignancy. Clinical Cancer Research 14:22, pages 7348-7357.
Crossref
Crossref
Tingyan Liu, Meixia Zhang, Hongliang Zhang, Chunyan Sun & Yihui Deng. (2008) Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology 265:10, pages 1225-1232.
Crossref
Crossref
Thorsten Berg. (2008) Signal Transducers and Activators of Transcription as Targets for Small Organic Molecules. ChemBioChem 9:13, pages 2039-2044.
Crossref
Crossref
Thorsten Berg. (2008) Inhibition of transcription factors with small organic molecules. Current Opinion in Chemical Biology 12:4, pages 464-471.
Crossref
Crossref
Clint Allen, Kunal Saigal, Liesl Nottingham, Pattatheyil Arun, Zhong Chen & Carter Van Waes. (2008) Bortezomib-Induced Apoptosis with Limited Clinical Response Is Accompanied by Inhibition of Canonical but not Alternative Nuclear Factor-κB Subunits in Head and Neck Cancer. Clinical Cancer Research 14:13, pages 4175-4185.
Crossref
Crossref
Amanda L. Boehm, Malabika Sen, Raja Seethala, William E. Gooding, Maria Freilino, Silvia Man Yan Wong, Shaomeng Wang, Daniel E. Johnson & Jennifer Rubin Grandis. (2008)
Combined Targeting of Epidermal Growth Factor Receptor, Signal Transducer and Activator of Transcription-3, and Bcl-X
L
Enhances Antitumor Effects in Squamous Cell Carcinoma of the Head and Neck
. Molecular Pharmacology 73:6, pages 1632-1642.
Crossref
Crossref
Tin Lap Lee, Jason Yeh, Jay Friedman, Bin Yan, Xinping Yang, Ning T. Yeh, Carter Van Waes & Zhong Chen. (2008) A signal network involving coactivated NF-κB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas. International Journal of Cancer 122:9, pages 1987-1998.
Crossref
Crossref
J. Wang, R. R. Seethala, Q. Zhang, W. Gooding, C. van Waes, H. Hasegawa & R. L. Ferris. (2008) Autocrine and Paracrine Chemokine Receptor 7 Activation in Head and Neck Cancer: Implications for Therapy. JNCI Journal of the National Cancer Institute 100:7, pages 502-512.
Crossref
Crossref
Juliana Xu, Renia Sylvester, Ann P. Tighe, Siming Chen & Lorraine J. Gudas. (2008) Transcriptional Activation of the Suppressor of Cytokine Signaling-3 (SOCS-3) Gene via STAT3 Is Increased in F9 REX1 (ZFP-42) Knockout Teratocarcinoma Stem Cells Relative to Wild-type Cells. Journal of Molecular Biology 377:1, pages 28-46.
Crossref
Crossref
Vyomesh Patel, Brian L. Hood, Alfredo A. Molinolo, Norman H. Lee, Thomas P. Conrads, John C. Braisted, David B. Krizman, Timothy D. Veenstra & J. Silvio Gutkind. (2008) Proteomic Analysis of Laser-Captured Paraffin-Embedded Tissues: A Molecular Portrait of Head and Neck Cancer Progression. Clinical Cancer Research 14:4, pages 1002-1014.
Crossref
Crossref
Ja Eun KimHong Sook KimYong-Jae ShinChang Seok LeeCheolhee WonSin-Ae LeeJung Weon LeeYoungsoo KimJae-Seung KangSang-Kyu YeMyung-Hee Chung. (2008) LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression. Experimental and Molecular Medicine 40:5, pages 514.
Crossref
Crossref
S. Choi & J.N. Myers. (2008) Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy. Journal of Dental Research 87:1, pages 14-32.
Crossref
Crossref
Priya Koppikar & Jennifer Rubin Grandis. 2008. EGFR Signaling Networks in Cancer Therapy. EGFR Signaling Networks in Cancer Therapy
69
83
.
Robert L. Ferris & Jennifer R. Grandis. (2007) NF-κB Gene Signatures and p53 Mutations in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research 13:19, pages 5663-5664.
Crossref
Crossref
Kelly M. Quesnelle, Amanda L. Boehm & Jennifer R. Grandis. (2007) STAT‐mediated EGFR signaling in cancer. Journal of Cellular Biochemistry 102:2, pages 311-319.
Crossref
Crossref
Alfredo A. Molinolo, Stephen M. Hewitt, Panomwat Amornphimoltham, Somboon Keelawat, Samraeung Rangdaeng, Abelardo Meneses García, Ana R. Raimondi, Rafael Jufe, María Itoiz, Yan Gao, Dhananjaya Saranath, George S. Kaleebi, George H. Yoo, Lee Leak, Ernest M. Myers, Satoru Shintani, David Wong, H. Davis Massey, W. Andrew Yeudall, Fulvio Lonardo, John Ensley & J. Silvio Gutkind. (2007) Dissecting the Akt/Mammalian Target of Rapamycin Signaling Network: Emerging Results from the Head and Neck Cancer Tissue Array Initiative. Clinical Cancer Research 13:17, pages 4964-4973.
Crossref
Crossref
Mazen Kurdi & George W Booz. (2007) Can the Protective Actions of JAK-STAT in the Heart be Exploited Therapeutically? Parsing the Regulation of Interleukin-6-Type Cytokine Signaling. Journal of Cardiovascular Pharmacology 50:2, pages 126-141.
Crossref
Crossref
M.B. Grace & W.F. Blakely. (2007) Transcription of five p53- and Stat-3-Inducible genes after ionizing radiation. Radiation Measurements 42:6-7, pages 1147-1151.
Crossref
Crossref
Michalis V. Karamouzis, Panagiotis A. Konstantinopoulos & Athanasios G. Papavassiliou. (2007) The role of STATs in lung carcinogenesis: an emerging target for novel therapeutics. Journal of Molecular Medicine 85:5, pages 427-436.
Crossref
Crossref
Jean-Philippe Spano, Gerard Milano, Clivier Rixe & Remi Fagard. (2006) JAK/STAT signalling pathway in colorectal cancer: A new biological target with therapeutic implications. European Journal of Cancer 42:16, pages 2668-2670.
Crossref
Crossref
Jochen Schust, Bianca Sperl, Angela Hollis, Thomas U. Mayer & Thorsten Berg. (2006) Stattic: A Small-Molecule Inhibitor of STAT3 Activation and Dimerization. Chemistry & Biology 13:11, pages 1235-1242.
Crossref
Crossref